
Jasper Therapeutics (JSPR) Earnings Dates & Reports
Jasper Therapeutics (JSPR) Most Recent Earnings
Report DateMay 12, 2025
Period EndingQ1 2025
Est. EPS-$1.48
Actual EPS-$1.41
EarningsBeat
Jasper Therapeutics (JSPR) Earnings
View the latest Jasper Therapeutics (JSPR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Jasper Therapeutics (JSPR)
Order type
Buy in
Order amount
Est. shares
0 shares
Jasper Therapeutics (JSPR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Jasper Therapeutics (JSPR) Latest Earnings
The value each JSPR share was expected to gain vs. the value each share gained.
Jasper Therapeutics (JSPR) reported its most recent earnings on May 12, 2025 for Q1 2025, posting earnings per share (EPS) of -$1.41. This exceeded analysts' expectations of -$1.48 by 4.73%, marking a Beat.
For comparison, Jasper Therapeutics reported EPS of -$1.03 in the same quarter last year.
The company is expected to announce its next earnings report on 08/12/2025, with analysts projecting an EPS of $0.
Jasper Therapeutics (JSPR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 12, 2025 | – | Next earnings call Aug. 12, 2025 | ||
Q1 2025May 12, 2025 | -$1.48 | -$1.41 | -4.73% | |
Q4 2024Feb 27, 2025 | -$1.26 | -$1.62 | +28.57% | |
Q3 2024Nov 7, 2024 | -$1.07 | -$1.24 | +15.89% | |
Q2 2024Aug 13, 2024 | -$1.09 | -$0.97 | -11.01% | |
Jasper Therapeutics (JSPR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Jasper Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 12, 2025 | — | — | — |
Feb 27, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Aug 13, 2024 | — | — | — |
Jasper Therapeutics (JSPR) Earnings FAQs
Jasper Therapeutics (JSPR) last reported earnings on May 12, 2025 for Q1 2025, posting an EPS of -$1.41, which Beat the estimate of -$1.48 by 4.73%.
For Q1 2025, Jasper Therapeutics (JSPR) reported an EPS of -$1.41, exceeding analysts' estimate of -$1.48 by 4.73%.
For Q1 2025, Jasper Therapeutics (JSPR) Beat expectations with an actual EPS of -$1.41 vs. an estimated EPS of -$1.48.
Following the last earnings report on May 12, 2025, Jasper Therapeutics (JSPR)'s stock price moved — from — to —.
The next Jasper Therapeutics (JSPR) earnings call is scheduled for Aug. 12, 2025, where executives will discuss financial results and outlook.